Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC

Published:2021-03 Issue: Volume:23 Page:89-100
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Chong Wei,Wang Zhe,Shang Liang,Jia Shengtao,Liu Jin,Fang Zhen,Du Fengying,Wu Hao,Liu Yang,Chen Yang,Chen Hao

Funder

Key Research and Development Program of Shandong Province, China

Academic Promotion Programme of Shandong First Medical University, China

Special Foundation for Taishan Scholars Program of Shandong Province, China

Research Incubation Funding of Shandong Provincial Hospital, China

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference56 articles.

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;Brahmer;N. Engl. J. Med.,2015

2. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma;Wolchok;N. Engl. J. Med.,2017

3. Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing;Rizvi;J. Clin. Oncol.,2018

4. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer;Hellmann;Cancer Cell,2018

5. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy;Cristescu;Science,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour mutational burden: clinical utility, challenges and emerging improvements;Nature Reviews Clinical Oncology;2024-08-27

2. A mutational signature and ARID1A mutation associated with outcome in hepatocellular carcinoma;Clinical and Translational Oncology;2024-08-23

3. Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer;Cell Reports;2024-07

4. Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations;The Oncologist;2024-06-22

5. Life quality improvement of patients with non-small cell lung cancer undergoing targeted therapy: A case study of continuous care;Medicine;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3